IRON
IRON
NASDAQ · Biotechnology

Disc Medicine Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$77.44
+0.00 (+0.00%)
As of Aug 8, 1:30 AM ET ·
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 18 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target -71.0% upside
Low Target $15.33
Average Target $22.47
High Target $35.88
Current Price $77.44
Current
$77.44
Target
$22.47
$15.33 $22.47 avg $35.88
Scenario Analysis
Bear Case
$15.33
-80.2%
Low target
Base Case
$22.47
-71.0%
Avg target
Bull Case
$35.88
+-53.7%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$99.50
-22.2% from high
52-Week Low
$40.00
+93.6% from low
50-Day SMA
$78.91
-1.9% vs SMA
200-Day SMA
$68.08
+13.7% vs SMA
RSI (14)
34.9
Neutral
Target vs 52W High
$22.47
-77.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 79% $257.58 +4.7%
AMGN
Amgen Inc
 Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -90.2%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -44.4%
BIIB
Biogen Inc
 Buy 44 64% $91.45 -56.0%